Results 301 to 310 of about 207,009 (370)

Multiple Sampling Capsule Robot for Studying Gut Microbiome

open access: yesAdvanced Intelligent Systems, EarlyView.
A multiple sampling capsule robot (MSCR) is developed for longitudinal gut microbiome analysis. Employing electromagnetic field control, the MSCR can locomote actively, precisely align the selected channel, and collect up to six microbiome samples with minimal cross‐contamination.
Sanghyeon Park   +3 more
wiley   +1 more source

Clinical Features of Glutamic Acid Decarboxylase-65 Neurological Autoimmunity: A Case Series From China. [PDF]

open access: yesCNS Neurosci Ther
Qiu Z   +18 more
europepmc   +1 more source

Artificial Intelligence‐Enhanced, Closed‐Loop Wearable Systems Toward Next‐Generation Diabetes Management

open access: yesAdvanced Intelligent Systems, EarlyView.
Recent advancements in wearable healthcare have brought accessible continuous glucose monitoring systems (CGMs) for diabetes management. To address the limitations of CGMs, closed‐loop systems utilizing monitored glucose levels for insulin dosing are being developed.
Wei Huang   +5 more
wiley   +1 more source

Higher prevalence of gestational diabetes in euthyroid women with thyroid autoimmunity who were expecting a female fetus. [PDF]

open access: yesEur Thyroid J
Prasai M   +8 more
europepmc   +1 more source

Autoimmune Diseases and Molecular Mimicry in Tuberculosis. [PDF]

open access: yesBiology (Basel)
Churilov LP   +5 more
europepmc   +1 more source

Increasing prevalence of thyroid autoimmunity in childhood type 1 diabetes in the pre-COVID but not during the COVID era. [PDF]

open access: yesFront Endocrinol (Lausanne)
Herczeg V   +9 more
europepmc   +1 more source

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy